QuidelOrtho grants RSUs, options to HR chief

QuidelOrtho Corporation’s Chief Human Resources Officer, Ronald Lee Bowman, reported equity awards on January 30, 2026.

Rhea-AI Filing Summary

QuidelOrtho Corporation’s Chief Human Resources Officer, Ronald Lee Bowman, reported equity awards on January 30, 2026. He received 36,152 restricted stock units, each representing one share of common stock, and 36,150 non-qualified stock options with a $27.17 exercise price expiring January 30, 2036.

Of the restricted stock units, 12,050 shares will vest on January 30, 2027, and the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029. The 36,150 stock options will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029. All holdings are reported as directly owned.

Insider Trade Summary

Grant/Award: 72,302 shares

Grant/Award 2 txns

Insider Bowman Ronald Lee

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	36,152	$0.00	$0.00
Grant/Award	Non-Qualified Stock Options	36,150	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 36,152 contracts (Direct); Non-Qualified Stock Options — 36,150 contracts (Direct)

Footnotes (3)

1. F1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
2. F2. 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.
3. F3. 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did QuidelOrtho (QDEL) report for Ronald Lee Bowman?

QuidelOrtho’s Chief Human Resources Officer, Ronald Lee Bowman, reported equity awards granted on January 30, 2026. He received restricted stock units and non-qualified stock options that provide potential future ownership of QuidelOrtho common stock, subject to multi-year vesting schedules running from 2027 through 2029.

How many restricted stock units did Ronald Lee Bowman receive at QuidelOrtho (QDEL)?

Ronald Lee Bowman received 36,152 restricted stock units, each representing one share of QuidelOrtho common stock. These units vest over three years, with 12,050 shares vesting on January 30, 2027, and the remaining 24,102 vesting in equal installments in 2028 and 2029.

What stock options were granted to Ronald Lee Bowman by QuidelOrtho (QDEL)?

Bowman was granted 36,150 non-qualified stock options on January 30, 2026, with an exercise price of $27.17 per share and an expiration date of January 30, 2036. These options vest in three equal annual installments from January 30, 2027 through January 30, 2029.

When do Ronald Lee Bowman’s QuidelOrtho (QDEL) restricted stock units vest?

The restricted stock units vest in stages: 12,050 shares vest on January 30, 2027. The remaining 24,102 units vest in two equal installments on January 30, 2028 and January 30, 2029, aligning the award with a three-year service and performance period.

What is the vesting schedule for Ronald Lee Bowman’s QuidelOrtho (QDEL) stock options?

The 36,150 non-qualified stock options vest in three equal installments on January 30, 2027, January 30, 2028, and January 30, 2029. This schedule spreads potential ownership benefits over several years, encouraging longer-term alignment with QuidelOrtho’s performance.

Are Ronald Lee Bowman’s QuidelOrtho (QDEL) equity awards directly owned?

Yes. The filing shows both the 36,152 restricted stock units and the 36,150 non-qualified stock options as directly owned by Ronald Lee Bowman. No indirect ownership entities or footnote disclaimers about voting or investment authority are indicated in this report.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 07:51 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bowman Ronald Lee

(Last) (First) (Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/30/2026		A		36,152		(2)	(2)	Common Stock	36,152	$0	36,152	D
Non-Qualified Stock Options	$27.17	01/30/2026		A		36,150		(3)	01/30/2036	Common Stock	36,150	$0	36,150	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.

3. 36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.

Remarks:

	/s/ Jennifer Ahn, attorney-in-fact for Ronald Lee Bowman	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.